drugset / Trial / NCT01769339

An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis

NCT01769339

Phase 4 Completed 115 enrolled Janssen Pharmaceutica
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of miconazole plus hydrocortisone cream in the treatment of participants with vulvar candidiasis (yeast infection of the vulva).

Timeline

Start
2009-01
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified Topical
Subject Miconazole Small molecule Topical